MIT engineers build nanoscale particles for personalized cancer vaccines
Antigen density on engineered virus coat shaped immune response in mouse study
MIT researchers have developed a nanoscale particle that could serve as a customizable delivery vehicle for personalized cancer vaccines, showing in a new study that a vaccine built on it made mice much less likely to develop colon tumors.